Research Article
ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma
Table 4
Univariate and multivariate Cox regression analyses of overall survival in 83 patients with ESCC.
and
.
| Parameter | Overall survival | Univariate analysis | Multivariate analysis | HR (95% CI) | | HR (95% CI) | |
| Age | 4.287 (1.262-14.564) | 0.02 | 3.225 (0.937-11.095) | 0.063 | Gender | 0.738 (0.311-1.751) | 0.49 | -- | -- | Tumor size | 1.526 (0.355-6.556) | 0.57 | T classification | 3.155 (0.817-12.181) | 0.095 | N classification | 2.055 (1.321-3.197) | 0.001 | 1.38 (0.616-3.094) | 0.434 | pTNM stage | 2.663 (1.543-4.594) | ≤0.001 | 2.031 (1.039-3.972) | 0.038 | Pathological differentiation | 1.468 (0.697-3.094) | 0.312 | -- | -- | Tumor embolus | 2.223 (0.517-9.555) | 0.283 | IHC score-ESM1 | 2.425 (1.027-5.726) | 0.043 | 1.506 (0.634-3.578) | 0.353 |
|
|